SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-324457
Filing Date
2021-11-09
Accepted
2021-11-09 16:11:38
Documents
14
Period of Report
2021-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d234616d8k.htm   iXBRL 8-K 25732
2 EX-99.1 d234616dex991.htm EX-99.1 190045
6 GRAPHIC g234616g1109061940334.jpg GRAPHIC 4765
  Complete submission text file 0001193125-21-324457.txt   364198

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA orgo-20211109.xsd EX-101.SCH 2896
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE orgo-20211109_lab.xml EX-101.LAB 18124
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE orgo-20211109_pre.xml EX-101.PRE 11408
7 EXTRACTED XBRL INSTANCE DOCUMENT d234616d8k_htm.xml XML 3398
Mailing Address 85 DAN ROAD CANTON MA 02021
Business Address 85 DAN ROAD CANTON MA 02021 781-575-0775
Organogenesis Holdings Inc. (Filer) CIK: 0001661181 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37906 | Film No.: 211392259
SIC: 2834 Pharmaceutical Preparations